,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,68324,403,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,68324,403,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,68324,403,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,68324,403,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,68324,403,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,68324,403,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,228,1,1,,68324,403,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
7,248,1,1,,68324,403,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
8,250,1,1,,68324,403,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
9,270,1,1,,68324,403,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
10,328,1,1,,68324,403,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
11,330,1,1,,68324,403,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
12,421,1,3,,17388802,403,Active,,,,,Cell Viability - BJ,Confirmatory,,
13,426,1,2,,17388802,403,Active,,,,,Cell Viability - Jurkat,Confirmatory,,
14,427,1,1,,17388802,403,Active,,,,,Cell Viability - Hek293,Confirmatory,,
15,433,1,1,,17388802,403,Inconclusive,,,,,Cell Viability - HepG2,Confirmatory,,
16,434,1,2,,17388802,403,Active,,,,,Cell Viability - MRC5,Confirmatory,,
17,435,1,2,,17388802,403,Active,,,,,Cell Viability - SK-N-SH,Confirmatory,,
18,445,3,1,,17388802,403,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
19,530,1,1,,17388802,403,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
20,540,1,1,,17388802,403,Active,,,,,Cell Viability - N2a,Confirmatory,,
21,541,1,1,,17388802,403,Active,,,,,Cell Viability - NIH 3T3,Confirmatory,,
22,542,1,1,,17388802,403,Active,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
23,543,1,1,,17388802,403,Active,,,,,Cell Viability - H-4-II-E,Confirmatory,,
24,544,2,1,,17388802,403,Active,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
25,545,1,1,,17388802,403,Active,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
26,546,1,1,,17388802,403,Active,,,,,Cell Viability - Mesenchymal,Confirmatory,,
27,584,1,3,,17388802,403,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
28,585,1,4,,17388802,403,Inconclusive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
29,595,1,3,,17388802,403,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
30,596,1,2,,17388802,403,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
31,603,1,2,,17388802,403,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
32,605,1,2,,17388802,403,Inconclusive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
33,654,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
34,655,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
35,656,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
36,657,1,1,,17388802,403,Inconclusive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
37,658,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
38,659,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
39,660,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
40,661,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
41,662,1,1,,17388802,403,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
42,663,1,1,,17388802,403,Inconclusive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
43,664,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
44,665,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
45,666,1,1,,17388802,403,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
46,667,1,1,,17388802,403,Inconclusive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
47,747,1,1,,24715001,403,Unspecified,4885617.0,6783.0,,,Basic StarGazer Assay on Human SULT1E1,Other,,
48,875,1,2,,17388802,403,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
49,880,2,1,,17388802,403,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
50,880,2,1,,17388802,403,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
51,881,2,2,,17388802,403,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
52,884,1,2,,17388802,403,Inconclusive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
53,885,1,2,,17388802,403,Inactive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
54,886,1,2,,17388802,403,Active,122921310.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
55,886,1,2,,17388802,403,Active,122921311.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
56,887,1,2,,17388802,403,Inconclusive,1832253.0,246.0,25.1189,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
57,889,1,3,,17388802,403,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
58,892,1,2,,17388802,403,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
59,893,1,2,,17388802,403,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
60,893,1,2,,17388802,403,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
61,894,2,1,,17388802,403,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
62,900,1,3,,17388802,403,Inconclusive,15431328.0,834.0,31.6228,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
63,902,1,2,,17388802,403,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
64,912,1,2,,17388802,403,Inconclusive,21392848.0,,31.6228,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
65,921,1,2,,17388802,403,Inconclusive,,,25.1189,Potency,Cell Viability - LYMP2-001,Confirmatory,,
66,923,1,2,,17388802,403,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
67,924,1,2,,17388802,403,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
68,925,1,2,,17388802,403,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
69,926,1,2,,17388802,403,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
70,938,1,2,,17388802,403,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
71,946,1,2,,17388802,403,Inconclusive,,,79.4328,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
72,947,1,2,,17388802,403,Inconclusive,,,63.0957,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
73,948,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
74,955,1,2,,17388802,403,Active,,,25.1189,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
75,960,1,2,,17388802,403,Active,,,31.6228,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
76,961,1,2,,17388802,403,Active,,,50.1187,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
77,962,1,2,,17388802,403,Inconclusive,,,79.4328,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
78,963,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
79,964,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
80,965,1,2,,17388802,403,Active,,,25.1189,Potency,Cell Viability - LYMP2-003,Confirmatory,,
81,966,1,2,,17388802,403,Active,,,25.1189,Potency,Cell Viability - LYMP2-004,Confirmatory,,
82,967,1,2,,17388802,403,Active,,,25.1189,Potency,Cell Viability - LYMP2-005,Confirmatory,,
83,968,1,2,,17388802,403,Active,,,31.6228,Potency,Cell Viability - LYMP2-009,Confirmatory,,
84,969,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP2-011,Confirmatory,,
85,970,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP2-013,Confirmatory,,
86,971,1,2,,17388802,403,Active,,,31.6228,Potency,Cell Viability - LYMP2-015,Confirmatory,,
87,972,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP2-017,Confirmatory,,
88,973,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP2-019,Confirmatory,,
89,974,1,2,,17388802,403,Active,,,31.6228,Potency,Cell Viability - LYMP2-021,Confirmatory,,
90,975,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP2-023,Confirmatory,,
91,976,1,2,,17388802,403,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-025,Confirmatory,,
92,977,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP2-002,Confirmatory,,
93,978,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP2-006,Confirmatory,,
94,979,1,2,,17388802,403,Active,,,31.6228,Potency,Cell Viability - LYMP2-007,Confirmatory,,
95,980,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP2-008,Confirmatory,,
96,981,1,2,,17388802,403,Active,,,25.1189,Potency,Cell Viability - LYMP2-010,Confirmatory,,
97,982,1,2,,17388802,403,Active,,,31.6228,Potency,Cell Viability - LYMP2-012,Confirmatory,,
98,983,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP2-014,Confirmatory,,
99,984,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP2-016,Confirmatory,,
100,985,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP2-018,Confirmatory,,
101,986,1,2,,17388802,403,Active,,,31.6228,Potency,Cell Viability - LYMP2-020,Confirmatory,,
102,987,1,2,,17388802,403,Active,,,25.1189,Potency,Cell Viability - LYMP2-022,Confirmatory,,
103,988,1,2,,17388802,403,Active,,,25.1189,Potency,Cell Viability - LYMP2-024,Confirmatory,,
104,989,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP2-026,Confirmatory,,
105,993,1,2,,17388802,403,Active,,,39.8107,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
106,994,1,2,,17388802,403,Active,,,50.1187,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
107,995,1,2,,17388802,403,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
108,1030,2,1,,17388802,403,Inconclusive,30582681.0,216.0,28.1838,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
109,1376,1,2,,47193681,403,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
110,1385,2,2,,47193681,403,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
111,1422,1,1,,47193681,403,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
112,1452,1,1,,17388802,403,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
113,1457,1,1,,17388802,403,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
114,1458,1,1,,17388802,403,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
115,1465,1,1,,47193681,403,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
116,1469,1,1,,17388802,403,Inconclusive,189491771.0,7068.0,35.4813,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
117,1471,2,1,,17388802,403,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
118,1476,2,1,,17388802,403,Inconclusive,281307097.0,,31.6228,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
119,1477,1,1,,17388802,403,Inconclusive,,,12.5893,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
120,1478,2,1,,17388802,403,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
121,1479,1,2,,17388802,403,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
122,1511,1,3,,47193681,403,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
123,1529,1,1,,47193681,403,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
124,1530,1,1,,47193681,403,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
125,1531,1,1,,47193681,403,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
126,1532,1,1,,47193681,403,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
127,1554,1,1,,47193681,403,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
128,1621,1,2,,47193681,403,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
129,1626,1,2,,47193681,403,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
130,1662,1,2,,47193681,403,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
131,1663,1,2,,47193681,403,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
132,1672,1,3,,47193681,403,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
133,1813,1,2,,47193681,403,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
134,1814,1,2,,47193681,403,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
135,1832,2,1,,47193681,403,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
136,1850,2,1,,47193681,403,Active,,,70.98,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
137,1863,2,1,,47193681,403,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
138,1875,2,1,,47193681,403,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
139,1885,2,1,,47193681,403,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
140,1899,1,3,,47193681,403,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
141,1903,2,3,,47193681,403,Inconclusive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
142,1906,1,3,,47193681,403,Active,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
143,1910,1,2,,47193681,403,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
144,1947,1,2,,47193681,403,Active,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
145,1948,1,1,,17388802,403,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
146,1950,1,3,,47193681,403,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
147,1956,1,1,,47193681,403,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
148,1962,1,2,,47193681,403,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
149,1974,1,2,,47193681,403,Active,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
150,1978,1,2,,47193681,403,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based confirmation biochemical high throughput screening assay for inhibitors of the serine hydrolase family member Fam108b.,Screening,,
151,1985,2,1,,47193681,403,Active,,,47.656000000000006,IC50,A screen for inhibitors of the PhoP regulon in Salmonella Typhi using a modified counterscreen,Confirmatory,,
152,1987,1,2,,47193681,403,Active,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
153,2016,1,3,,47193681,403,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
154,2023,1,3,,47193681,403,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
155,2025,1,3,,47193681,403,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
156,2029,1,3,,47193681,403,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
157,2052,2,1,,47193681,403,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
158,2057,1,2,,47193681,403,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
159,2066,1,4,,47193681,403,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
160,2094,1,2,,47193681,403,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
161,2094,1,2,,47193681,403,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
162,2094,1,2,,47193681,403,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
163,2097,1,2,,47193681,403,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
164,2098,1,1,,47193681,403,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
165,2099,1,1,,47193681,403,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
166,2101,1,1,,17388802,403,Inconclusive,496369.0,2629.0,12.5893,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
167,2107,1,1,,17388802,403,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
168,2112,1,1,,17388802,403,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
169,2120,1,1,,17388802,403,Inconclusive,32879895.0,3091.0,50.1187,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
170,2129,1,2,,47193681,403,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
171,2130,1,3,,47193681,403,Active,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
172,2156,2,2,,47193681,403,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
173,2174,1,3,,47193681,403,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
174,2177,1,3,,47193681,403,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
175,2216,1,3,,47193681,403,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
176,2221,1,2,,47193681,403,Active,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
177,2227,1,2,,47193681,403,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
178,2234,1,2,,47193681,403,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
179,2235,1,2,,47193681,403,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
180,2237,1,2,,47193681,403,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
181,2239,1,2,,47193681,403,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
182,2247,1,2,,47193681,403,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
183,2252,1,1,,47193681,403,Active,,,18.53,EC50,A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen,Confirmatory,,
184,2280,2,3,,47193681,403,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
185,2300,1,3,,47193681,403,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
186,2331,1,2,,47193681,403,Inactive,37589898.0,5536.0,,,Fluorescence-based biochemical high throughput confirmation assay for inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
187,2355,1,2,,47193681,403,Inactive,56790945.0,5499.0,,,"Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput assay for inhibitors of Protein Phosphatase 1 (PP1), in triplicate.",Screening,,
188,2384,1,1,,47193681,403,Active,,,70.57,IC50,A counter screen for small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
189,2391,1,1,,47193681,403,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
190,2435,1,2,,47193681,403,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
191,2445,1,2,,47193681,403,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
192,2462,1,1,,47193681,403,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
193,2462,1,1,,47193681,403,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
194,2517,2,1,,17388802,403,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
195,2546,1,1,,17388802,403,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
196,2549,1,1,,17388802,403,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
197,2550,1,3,,47193681,403,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
198,2551,1,1,,17388802,403,Inconclusive,188536040.0,19885.0,17.7828,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
199,2553,1,2,,47193681,403,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
200,2557,1,3,,47193681,403,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
201,2563,1,1,,47193681,403,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
202,2606,1,2,,47193681,403,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
203,2629,1,1,,47193681,403,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
204,2642,1,2,,47193681,403,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
205,2648,1,2,,47193681,403,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
206,2650,2,1,,47193681,403,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
207,2661,1,1,,47193681,403,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
208,2690,1,2,,47193681,403,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
209,2716,1,1,,47193681,403,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
210,2717,1,2,,47193681,403,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
211,2718,1,1,,47193681,403,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
212,2751,2,2,,47193681,403,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
213,2796,1,4,,47193681,403,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
214,2797,1,2,,47193681,403,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
215,25611,3,3,,103329767,403,Unspecified,,,,,Dissociation constant (pKa),Other,6802973.0,
216,26261,4,3,,103329767,403,Unspecified,,,,,Partition coefficient (logD7.2),Other,6802973.0,
217,26793,3,3,,103329767,403,Unspecified,,,,,Partition coefficient (logP),Other,6802973.0,
218,40625,5,2,,103329767,403,Unspecified,,,,,Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined; No inhibition at 5e-2M,Other,6802973.0,
219,40937,3,5,,103329767,403,Unspecified,,,,,"Inhibitory activity on germination of Bacillus subtilis PCI219 spores, expressed as log 1/I50; No inhibition at 5 x E-2 M",Other,6802973.0,
220,303043,4,4,,103329767,403,Active,,,41.979,IC50,Cytotoxicity against human MIA PaCa2 cells after 4 hrs by MTT assay,Confirmatory,17944451.0,
221,303044,4,4,,103329767,403,Active,,,42.25,IC50,Cytotoxicity against human MIA PaCa2 cells after 72 hrs by MTT assay,Confirmatory,17944451.0,
222,331291,9,5,,103329767,403,Unspecified,115449.0,759.0,159.0,Ki,Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay,Confirmatory,18501600.0,
223,331292,9,5,,103329767,403,Unspecified,115456.0,760.0,752.0,Ki,Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay,Confirmatory,18501600.0,
224,331293,9,5,,103329767,403,Unspecified,30580362.0,80733.0,335.0,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay,Confirmatory,18501600.0,
225,342475,9,5,,103329767,403,Unspecified,115449.0,759.0,159.0,Ki,Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
226,342476,9,5,,103329767,403,Unspecified,115456.0,760.0,752.0,Ki,Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
227,342477,9,5,,103329767,403,Active,134047703.0,761.0,9.5,Ki,Inhibition of human carbonic anhydrase 3 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
228,342478,9,5,,103329767,403,Unspecified,115465.0,762.0,743.0,Ki,Inhibition of human carbonic anhydrase 4 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
229,342479,9,5,,103329767,403,Unspecified,461680.0,763.0,867.0,Ki,Inhibition of human carbonic anhydrase 5A by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
230,342480,9,5,,103329767,403,Unspecified,8928041.0,11238.0,649.0,Ki,Inhibition of human carbonic anhydrase 5B by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
231,342481,9,5,,103329767,403,Active,116241278.0,765.0,23.5,Ki,Inhibition of human carbonic anhydrase 6 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
232,342482,9,5,,103329767,403,Unspecified,1168744.0,766.0,1359.0,Ki,Inhibition of human carbonic anhydrase 7 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
233,342483,9,5,,103329767,403,Unspecified,83300925.0,768.0,517.0,Ki,Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
234,342484,9,5,,103329767,403,Unspecified,5915866.0,771.0,479.0,Ki,Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
235,342485,9,5,,103329767,403,Active,8928036.0,23632.0,10.1,Ki,Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
236,342486,9,5,,103329767,403,Unspecified,30580372.0,71934.0,657.0,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay,Confirmatory,18579385.0,
237,434955,1,2,,47193681,403,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
238,434962,1,2,,47193681,403,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
239,434968,1,1,,47193681,403,Active,15609874.0,888371.0,31.42,EC50_uM,Fluorescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of GFP Chromophore Formation,Confirmatory,,
240,434989,1,1,,47193681,403,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
241,435005,1,1,,47193681,403,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
242,435010,1,3,,47193681,403,Inconclusive,15609874.0,888371.0,380.0,EC50_uM,Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity,Confirmatory,,
243,435030,1,2,,47193681,403,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
244,435030,1,2,,47193681,403,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
245,449728,1,2,,47193681,403,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
246,449749,1,2,,47193681,403,Inactive,15607200.0,887009.0,380.0,AC50_uM,Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Inhibitors of DnaB-Intein Splicing Activity,Confirmatory,,
247,449750,1,2,,47193681,403,Active,15607200.0,887009.0,40.6,AC50_uM,Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Non-Covalent Inhibitors of RecA-Intein Splicing Activity,Confirmatory,,
248,449762,1,2,,47193681,403,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
249,449768,1,1,,47193681,403,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
250,457006,6,2,,103329767,403,Unspecified,,,90.0,IC50,Inhibition of amyloid beta (1-40) fibril formation by thioflavin T formation assay,Confirmatory,20149667.0,
251,457007,6,2,,103329767,403,Unspecified,,,83.0,IC50,Inhibition of fibril formation of amyloid beta (1-40) catalytic domain containing HHQKLVFFAED sequence by thioflavin T assay,Confirmatory,20149667.0,
252,463079,1,2,,47193681,403,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
253,463082,1,1,,47193681,403,Active,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
254,463111,1,1,,47193681,403,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
255,463141,1,2,,47193681,403,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
256,463165,1,1,,47193681,403,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
257,463210,1,2,,47193681,403,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
258,485270,1,1,,47193681,403,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
259,485272,1,1,,47193681,403,Active,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
260,485275,1,3,,47193681,403,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
261,485290,1,1,,17388802,403,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
262,485317,1,2,,47193681,403,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
263,488847,1,3,,47193681,403,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
264,488890,1,2,,47193681,403,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
265,488922,1,2,,47193681,403,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
266,488975,1,2,,47193681,403,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
267,488977,1,2,,47193681,403,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
268,504339,1,1,,17388802,403,Inconclusive,162330054.0,,10.0,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
269,504406,1,1,,47193681,403,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
270,504408,2,1,,47193681,403,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
271,504444,1,1,,17388802,403,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
272,504648,1,1,,17388802,403,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
273,504845,1,1,,17388802,403,Inconclusive,86301163.0,5999.0,44.6684,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
274,504847,1,1,,17388802,403,Active,63054845.0,7421.0,79.4328,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
275,540267,1,1,,17388802,403,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
276,540317,1,1,,17388802,403,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
277,588210,2,4,,103329767,403,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
278,588453,1,1,,17388802,403,Active,8659577.0,58819.0,14.1254,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
279,588456,1,1,,17388802,403,Inconclusive,8659577.0,58819.0,8.9125,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
280,588511,1,2,,47193681,403,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
281,588513,1,1,,17388802,403,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
282,588514,1,1,,17388802,403,Inconclusive,348019627.0,2099.0,28.1838,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
283,588515,1,1,,17388802,403,Inconclusive,124375976.0,367.0,44.6684,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
284,588516,1,1,,17388802,403,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
285,588526,1,1,,17388802,403,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
286,588527,1,1,,17388802,403,Inconclusive,325495553.0,9971.0,44.6684,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
287,588532,1,1,,17388802,403,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
288,588533,1,1,,17388802,403,Inconclusive,311348376.0,2908.0,31.6228,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
289,588534,1,1,,17388802,403,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
290,588535,1,1,,17388802,403,Inconclusive,216409690.0,5467.0,17.7828,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
291,588536,1,1,,17388802,403,Inconclusive,216409692.0,5468.0,17.7828,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
292,588537,1,1,,17388802,403,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
293,588541,1,1,,17388802,403,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
294,588543,1,1,,17388802,403,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
295,588544,1,1,,17388802,403,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
296,588545,1,1,,17388802,403,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
297,588546,1,1,,17388802,403,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
298,588547,1,1,,17388802,403,Inconclusive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
299,588579,1,1,,17388802,403,Active,7705344.0,51426.0,89.1251,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
300,588590,1,1,,17388802,403,Active,154350220.0,11201.0,7.0795,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
301,588627,1,1,,47193681,403,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
302,588675,1,1,,47193681,403,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
303,588676,1,1,,47193681,403,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
304,588795,1,1,,17388802,403,Inconclusive,4758356.0,2237.0,10.0,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
305,588812,1,1,,17388802,403,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
306,588812,1,1,1.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
307,588812,1,1,2.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
308,588812,1,1,3.0,17388802,403,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
309,588812,1,1,4.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
310,588812,1,1,5.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
311,588812,1,1,6.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
312,588812,1,1,7.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
313,588812,1,1,8.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
314,588812,1,1,9.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
315,588812,1,1,10.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
316,588812,1,1,11.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
317,588812,1,1,12.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
318,588812,1,1,13.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
319,588812,1,1,14.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
320,588812,1,1,15.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
321,588812,1,1,16.0,17388802,403,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
322,588812,1,1,17.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
323,588812,1,1,18.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
324,588812,1,1,19.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
325,588812,1,1,20.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
326,588812,1,1,21.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
327,588812,1,1,22.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
328,588812,1,1,23.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
329,588812,1,1,24.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
330,588812,1,1,25.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
331,588812,1,1,26.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
332,588812,1,1,27.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
333,588812,1,1,28.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
334,588812,1,1,29.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
335,588812,1,1,30.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
336,588812,1,1,31.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
337,588812,1,1,32.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
338,588812,1,1,33.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
339,588812,1,1,34.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
340,588812,1,1,35.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
341,588812,1,1,36.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
342,588812,1,1,37.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
343,588812,1,1,38.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
344,588812,1,1,39.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
345,588812,1,1,40.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
346,588812,1,1,41.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
347,588812,1,1,42.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
348,588812,1,1,43.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
349,588812,1,1,44.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
350,588812,1,1,45.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
351,588812,1,1,46.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
352,588812,1,1,47.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
353,588812,1,1,48.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
354,588812,1,1,49.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
355,588812,1,1,50.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
356,588812,1,1,51.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
357,588812,1,1,52.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
358,588812,1,1,53.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
359,588812,1,1,54.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
360,588812,1,1,55.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
361,588812,1,1,56.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
362,588812,1,1,57.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
363,588812,1,1,58.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
364,588812,1,1,59.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
365,588812,1,1,60.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
366,588812,1,1,61.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
367,588812,1,1,62.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
368,588812,1,1,63.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
369,588812,1,1,64.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
370,588812,1,1,65.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
371,588812,1,1,66.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
372,588812,1,1,67.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
373,588812,1,1,68.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
374,588812,1,1,69.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
375,588812,1,1,70.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
376,588812,1,1,71.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
377,588812,1,1,72.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
378,588812,1,1,73.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
379,588812,1,1,74.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
380,588812,1,1,75.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
381,588812,1,1,76.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
382,588812,1,1,77.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
383,588812,1,1,78.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
384,588812,1,1,79.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
385,588812,1,1,80.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
386,588812,1,1,81.0,17388802,403,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
387,588813,1,1,,17388802,403,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
388,588813,1,1,1.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
389,588813,1,1,2.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
390,588813,1,1,3.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
391,588813,1,1,4.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
392,588813,1,1,5.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
393,588813,1,1,6.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
394,588813,1,1,7.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
395,588813,1,1,8.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
396,588813,1,1,9.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
397,588813,1,1,10.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
398,588813,1,1,11.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
399,588813,1,1,12.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
400,588813,1,1,13.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
401,588813,1,1,14.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
402,588813,1,1,15.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
403,588813,1,1,16.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
404,588813,1,1,17.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
405,588813,1,1,18.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
406,588813,1,1,19.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
407,588813,1,1,20.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
408,588813,1,1,21.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
409,588813,1,1,22.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
410,588813,1,1,23.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
411,588813,1,1,24.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
412,588813,1,1,25.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
413,588813,1,1,26.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
414,588813,1,1,27.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
415,588813,1,1,28.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
416,588813,1,1,29.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
417,588813,1,1,30.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
418,588813,1,1,31.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
419,588813,1,1,32.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
420,588813,1,1,33.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
421,588813,1,1,34.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
422,588813,1,1,35.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
423,588813,1,1,36.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
424,588813,1,1,37.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
425,588813,1,1,38.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
426,588813,1,1,39.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
427,588813,1,1,40.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
428,588813,1,1,41.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
429,588813,1,1,42.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
430,588813,1,1,43.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
431,588813,1,1,44.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
432,588813,1,1,45.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
433,588813,1,1,46.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
434,588813,1,1,47.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
435,588813,1,1,48.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
436,588813,1,1,49.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
437,588813,1,1,50.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
438,588813,1,1,51.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
439,588813,1,1,52.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
440,588813,1,1,53.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
441,588813,1,1,54.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
442,588813,1,1,55.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
443,588813,1,1,56.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
444,588813,1,1,57.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
445,588813,1,1,58.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
446,588813,1,1,59.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
447,588813,1,1,60.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
448,588813,1,1,61.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
449,588813,1,1,62.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
450,588813,1,1,63.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
451,588813,1,1,64.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
452,588813,1,1,65.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
453,588813,1,1,66.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
454,588813,1,1,67.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
455,588813,1,1,68.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
456,588813,1,1,69.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
457,588813,1,1,70.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
458,588813,1,1,71.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
459,588813,1,1,72.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
460,588813,1,1,73.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
461,588813,1,1,74.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
462,588813,1,1,75.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
463,588813,1,1,76.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
464,588813,1,1,77.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
465,588813,1,1,78.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
466,588813,1,1,79.0,17388802,403,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
467,588813,1,1,80.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
468,588813,1,1,81.0,17388802,403,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
469,588834,2,1,,17388802,403,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
470,588855,1,1,,17388802,403,Active,18418623.0,4088.0,4.4668,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
471,588856,1,1,,17388802,403,Active,,,14.1254,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
472,602310,1,2,,17388802,403,Inconclusive,13399304.0,60489.0,35.4813,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
473,602332,1,1,,17388802,403,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
474,602332,1,1,,124890037,403,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
475,624030,1,2,,17388802,403,Inconclusive,160794.0,,12.8178,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
476,624030,1,2,,124890037,403,Inconclusive,160794.0,,33.1616,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
477,624170,1,1,,17388802,403,Active,71051501.0,2744.0,12.5893,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
478,624170,1,1,,124890037,403,Inconclusive,71051501.0,2744.0,17.7828,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
479,624172,1,1,,17388802,403,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
480,624172,1,1,,124890037,403,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
481,624173,1,3,,17388802,403,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
482,624173,1,3,,124890037,403,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
483,624178,1,1,,17388802,403,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
484,624202,1,1,,17388802,403,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
485,624263,1,1,,17388802,403,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
486,624263,1,1,,17388802,403,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
487,624414,1,1,,17388802,403,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
488,624608,3,2,,103329767,403,Unspecified,136731.0,54657.0,,,Specific activity of expressed human recombinant UGT1A4,Other,10836148.0,
489,624609,1,9,,103329767,403,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
490,624612,1,9,,103329767,403,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
491,624617,1,8,,103329767,403,Unspecified,6136104.0,7367.0,,,Specific activity of expressed human recombinant UGT2B17,Other,10836148.0,
492,624619,3,2,,103329767,403,Unspecified,136727.0,7364.0,,,Specific activity of expressed human recombinant UGT2B7,Other,10836148.0,
493,651631,4,1,,144206793,403,Active,269849759.0,7157.0,26.6032,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
494,651631,4,1,,144207026,403,Active,269849759.0,7157.0,30.6379,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
495,651631,4,1,,144208228,403,Inconclusive,269849759.0,7157.0,50.4402,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
496,651632,4,1,,144206793,403,Active,296439460.0,79915.0,29.8493,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
497,651632,4,1,,144207026,403,Active,296439460.0,79915.0,61.1306,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
498,651632,4,1,,144208228,403,Inconclusive,296439460.0,79915.0,56.5948,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
499,651633,4,1,,144206793,403,Active,,,26.6032,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
500,651633,4,1,,144207026,403,Active,,,30.6379,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
501,651633,4,1,,144208228,403,Active,,,31.8256,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
502,651634,4,1,,144206793,403,Active,,,13.3332,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
503,651634,4,1,,144207026,403,Inconclusive,,,76.9588,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
504,651634,4,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
505,651741,1,1,,17388802,403,Active,20149576.0,4780.0,26.6032,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
506,651743,1,1,,17388802,403,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
507,651749,1,1,,17388802,403,Inconclusive,34577122.0,4790.0,35.4813,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
508,651751,1,1,,17388802,403,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
509,651754,1,1,,17388802,403,Active,,,6.6824,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
510,651755,1,1,,17388802,403,Active,,,7.4978,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
511,651757,1,1,,17388802,403,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
512,651758,1,1,,17388802,403,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
513,651777,1,1,,17388802,403,Inconclusive,51095037.0,196.0,39.8107,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
514,651778,1,1,,17388802,403,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
515,651802,1,1,,17388802,403,Inconclusive,49066040.0,6097.0,42.1632,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
516,651838,1,1,,17388802,403,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
517,651838,1,1,1.0,17388802,403,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
518,651838,1,1,2.0,17388802,403,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
519,651838,1,1,3.0,17388802,403,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
520,651838,1,1,4.0,17388802,403,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
521,651838,1,1,5.0,17388802,403,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
522,651838,1,1,6.0,17388802,403,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
523,651838,1,1,7.0,17388802,403,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
524,651838,1,1,8.0,17388802,403,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
525,651965,1,1,,17388802,403,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
526,652048,1,2,,144206793,403,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
527,652048,1,2,,144207026,403,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
528,652051,1,1,,144206793,403,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
529,652051,1,1,,144207026,403,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
530,652106,1,1,,144206793,403,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
531,686978,1,1,,144206793,403,Active,79154014.0,55775.0,6.3096,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
532,686978,1,1,,144207026,403,Active,79154014.0,55775.0,12.1972,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
533,686979,1,1,,144206793,403,Active,79154014.0,55775.0,6.3096,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
534,686979,1,1,,144207026,403,Active,79154014.0,55775.0,7.6959,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
535,697840,1,2,,103329767,403,Unspecified,,,,,Inhibition of HFIP-induced amyloid beta (1 to 40) aggregation at 250 uM after 45 mins by thioflavin T fluorescence method,Other,23062825.0,
536,720516,2,1,,144206793,403,Active,296439460.0,79915.0,29.8493,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
537,720516,2,1,,144207026,403,Active,296439460.0,79915.0,61.1306,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
538,720516,2,1,,144208228,403,Inconclusive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
539,720532,1,1,,144206793,403,Inconclusive,420597.0,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
540,720532,1,1,,144207026,403,Active,420597.0,,50.1187,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
541,720533,1,1,,144206793,403,Inconclusive,,,31.6228,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
542,720533,1,1,,144207026,403,Active,,,44.6684,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
543,720540,1,1,,144206793,403,Inconclusive,26667227.0,2139.0,19.0148,Potency,qHTS for Inhibitors of the Phosphatase Activity of Eya2: Confirmatory Assay for Cherry-picked Compounds,Confirmatory,,
544,720541,1,1,,144206793,403,Active,6014741.0,1487.0,11.9975,Potency,qHTS for Inhibitors of the Phosphatase Activity of Eya2: Carboxyl-terminal binding protein (CtBP) Counterscreen for Cherry-picked Compounds,Confirmatory,,
545,720552,2,1,,144206793,403,Inconclusive,269849759.0,7157.0,28.1796,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
546,720552,2,1,,144207026,403,Active,269849759.0,7157.0,33.082,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
547,720552,2,1,,144208228,403,Inconclusive,269849759.0,7157.0,67.2631,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
548,720579,2,1,,144206793,403,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
549,720580,1,1,,144206793,403,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
550,720634,2,1,,144206793,403,Inconclusive,,,8.4127,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
551,720634,2,1,,144207026,403,Inconclusive,,,38.5708,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
552,720634,2,1,,144208228,403,Active,,,31.8256,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
553,720635,2,1,,144206793,403,Active,,,0.8413,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
554,720635,2,1,,144207026,403,Active,,,3.0638,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
555,720635,2,1,,144208228,403,Active,,,0.897,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
556,720636,1,1,,17388802,403,Inconclusive,20149576.0,4780.0,26.6032,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
557,720637,2,1,,144206793,403,Active,,,1.10053,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
558,720637,2,1,,144207026,403,Active,,,4.00798,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
559,720637,2,1,,144208228,403,Active,,,1.24292,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
560,720652,1,1,,17388802,403,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
561,720653,1,1,,17388802,403,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
562,720659,1,1,,17388802,403,Inconclusive,325495557.0,8856.0,35.4813,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
563,720674,2,2,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
564,720674,2,2,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
565,720674,2,2,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
566,720675,2,2,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
567,720675,2,2,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
568,720675,2,2,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
569,720678,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
570,720678,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
571,720678,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
572,720679,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
573,720679,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
574,720679,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
575,720680,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
576,720680,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
577,720680,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
578,720681,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
579,720681,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
580,720681,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
581,720682,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
582,720682,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
583,720682,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
584,720683,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
585,720683,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
586,720683,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
587,720684,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
588,720684,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
589,720684,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
590,720685,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
591,720685,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
592,720685,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
593,720686,2,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
594,720686,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
595,720686,2,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
596,720687,2,2,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
597,720687,2,2,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
598,720687,2,2,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
599,720691,4,1,,144206793,403,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
600,720691,4,1,,144207026,403,Inconclusive,311348376.0,2908.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
601,720691,4,1,,144208228,403,Inconclusive,311348376.0,2908.0,16.0965,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
602,720692,3,1,,144206793,403,Inconclusive,311348376.0,2908.0,6.007000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
603,720692,3,1,,144207026,403,Active,311348376.0,2908.0,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
604,720692,3,1,,144208228,403,Inconclusive,311348376.0,2908.0,40.4326,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
605,720693,3,1,,144206793,403,Active,,,15.089,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
606,720693,3,1,,144207026,403,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
607,720693,3,1,,144208228,403,Active,,,25.5112,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
608,720719,2,1,,144206793,403,Inconclusive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
609,720719,2,1,,144207026,403,Inconclusive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
610,720719,2,1,,144208228,403,Inconclusive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
611,720725,2,1,,144206793,403,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
612,720725,2,1,,144207026,403,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
613,720725,2,1,,144208228,403,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
614,743012,3,1,,144206793,403,Active,,,5.308,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
615,743012,3,1,,144207026,403,Active,,,7.6959,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
616,743012,3,1,,144208228,403,Active,,,15.9506,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
617,743014,3,1,,144206793,403,Active,,,7.4978,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
618,743014,3,1,,144207026,403,Active,,,13.6854,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
619,743014,3,1,,144208228,403,Active,,,7.9942,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
620,743015,3,1,,144206793,403,Active,,,6.6824,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
621,743015,3,1,,144207026,403,Active,,,12.1972,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
622,743015,3,1,,144208228,403,Active,,,14.216,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
623,743033,3,1,,144206793,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
624,743033,3,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
625,743033,3,1,,144208228,403,Inconclusive,,,22.7369,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
626,743035,2,1,,144206793,403,Inconclusive,124375976.0,367.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
627,743035,2,1,,144207026,403,Inconclusive,124375976.0,367.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
628,743035,2,1,,144208228,403,Inconclusive,124375976.0,367.0,12.7859,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
629,743036,2,1,,144206793,403,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
630,743036,2,1,,144207026,403,Inconclusive,124375976.0,367.0,12.2998,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
631,743036,2,1,,144208228,403,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
632,743040,3,1,,144206793,403,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
633,743040,3,1,,144207026,403,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
634,743040,3,1,,144208228,403,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
635,743041,3,1,,144206793,403,Active,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
636,743041,3,1,,144207026,403,Active,,,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
637,743041,3,1,,144208228,403,Active,,,56.5948,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
638,743042,3,1,,144206793,403,Active,124375976.0,367.0,5.9557,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
639,743042,3,1,,144207026,403,Active,124375976.0,367.0,12.1972,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
640,743042,3,1,,144208228,403,Active,124375976.0,367.0,25.28,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
641,743053,2,1,,144206793,403,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
642,743053,2,1,,144207026,403,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
643,743053,2,1,,144208228,403,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
644,743054,2,1,,144206793,403,Inconclusive,124375976.0,367.0,9.80846,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
645,743054,2,1,,144207026,403,Inconclusive,124375976.0,367.0,26.278000000000002,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
646,743054,2,1,,144208228,403,Inconclusive,124375976.0,367.0,20.0806,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
647,743063,2,1,,144206793,403,Inconclusive,124375976.0,367.0,23.9145,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
648,743063,2,1,,144207026,403,Active,124375976.0,367.0,38.8952,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
649,743063,2,1,,144208228,403,Inconclusive,124375976.0,367.0,11.3954,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
650,743064,3,1,,144206793,403,Active,,,8.4127,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
651,743064,3,1,,144207026,403,Active,,,17.2289,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
652,743064,3,1,,144208228,403,Active,,,14.216,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
653,743065,3,1,,144206793,403,Active,399498506.0,24831.0,8.4127,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
654,743065,3,1,,144207026,403,Active,399498506.0,24831.0,19.3312,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
655,743065,3,1,,144208228,403,Active,399498506.0,24831.0,14.216,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
656,743066,3,1,,144206793,403,Inconclusive,399498506.0,24831.0,18.8336,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
657,743066,3,1,,144207026,403,Inconclusive,399498506.0,24831.0,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
658,743066,3,1,,144208228,403,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
659,743067,2,1,,144206793,403,Inconclusive,399498506.0,24831.0,9.0838,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
660,743067,2,1,,144207026,403,Inconclusive,399498506.0,24831.0,17.2289,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
661,743067,2,1,,144208228,403,Inconclusive,399498506.0,24831.0,16.3221,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
662,743069,2,1,,144206793,403,Inconclusive,348019627.0,2099.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
663,743069,2,1,,144207026,403,Inconclusive,348019627.0,2099.0,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
664,743069,2,1,,144208228,403,Inconclusive,348019627.0,2099.0,22.7369,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
665,743074,2,1,,144206793,403,Inconclusive,,,10.6822,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
666,743074,2,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
667,743074,2,1,,144208228,403,Inconclusive,,,50.9016,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
668,743075,2,1,,144206793,403,Inconclusive,348019627.0,2099.0,9.5112,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
669,743075,2,1,,144207026,403,Inconclusive,348019627.0,2099.0,19.4938,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
670,743075,2,1,,144208228,403,Inactive,348019627.0,2099.0,45.3661,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
671,743077,2,1,,144206793,403,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
672,743077,2,1,,144207026,403,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
673,743077,2,1,,144208228,403,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
674,743078,2,1,,144206793,403,Inconclusive,348019627.0,2099.0,26.8325,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
675,743078,2,1,,144207026,403,Inconclusive,348019627.0,2099.0,54.941,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
676,743078,2,1,,144208228,403,Inconclusive,348019627.0,2099.0,43.3243,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
677,743079,3,1,,144206793,403,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
678,743079,3,1,,144207026,403,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
679,743079,3,1,,144208228,403,Inconclusive,348019627.0,2099.0,71.2487,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
680,743080,3,1,,144206793,403,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
681,743080,3,1,,144207026,403,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
682,743080,3,1,,144208228,403,Inconclusive,348019627.0,2099.0,63.5004,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
683,743081,3,1,,144206793,403,Inconclusive,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
684,743081,3,1,,144207026,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
685,743081,3,1,,144208228,403,Active,,,63.5004,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
686,743083,3,1,,144206793,403,Inconclusive,119597822.0,1588.0,33.4915,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
687,743083,3,1,,144207026,403,Inactive,119597822.0,1588.0,21.6899,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
688,743083,3,1,,144208228,403,Active,119597822.0,1588.0,31.8256,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
689,743084,3,1,,144206793,403,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
690,743084,3,1,,144207026,403,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
691,743084,3,1,,144208228,403,Active,,,31.8256,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
692,743085,3,1,,144206793,403,Active,51095037.0,196.0,14.9601,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
693,743085,3,1,,144207026,403,Active,51095037.0,196.0,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
694,743085,3,1,,144208228,403,Active,51095037.0,196.0,17.8969,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
695,743086,3,1,,144206793,403,Inconclusive,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
696,743086,3,1,,144207026,403,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
697,743086,3,1,,144208228,403,Active,,,50.4402,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
698,743091,2,1,,144206793,403,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
699,743091,2,1,,144207026,403,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
700,743091,2,1,,144208228,403,Inconclusive,348019627.0,2099.0,63.5004,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
701,743094,3,1,,144206793,403,Inconclusive,216409692.0,5468.0,3.0107,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
702,743094,3,1,,144207026,403,Inconclusive,216409692.0,5468.0,24.5412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
703,743094,3,1,,144208228,403,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
704,743122,2,1,,144206793,403,Active,51095037.0,196.0,19.9496,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
705,743122,2,1,,144207026,403,Active,51095037.0,196.0,32.4533,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
706,743122,2,1,,144208228,403,Active,51095037.0,196.0,15.9506,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
707,743139,2,1,,144206793,403,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
708,743139,2,1,,144207026,403,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
709,743139,2,1,,144208228,403,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
710,743140,2,1,,144206793,403,Active,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
711,743140,2,1,,144207026,403,Active,216409692.0,5468.0,5.4941,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
712,743140,2,1,,144208228,403,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
713,743191,3,1,,144208228,403,Inconclusive,216409692.0,5468.0,1.8061,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
714,743191,3,1,,170466875,403,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
715,743194,3,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
716,743194,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
717,743199,2,1,,144208228,403,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
718,743199,2,1,,170466875,403,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
719,743202,4,1,,144208228,403,Inconclusive,20149576.0,4780.0,10.0641,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
720,743202,4,1,,170466875,403,Active,20149576.0,4780.0,29.846999999999998,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
721,743203,3,1,,144208228,403,Active,,,12.67,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
722,743203,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
723,743209,3,1,,144208228,403,Active,,,25.5112,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
724,743209,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
725,743210,4,1,,144208228,403,Inconclusive,4504517.0,3315.0,25.5112,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
726,743210,4,1,,170466875,403,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
727,743211,3,1,,144208228,403,Inconclusive,,,14.345999999999998,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
728,743211,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
729,743212,3,1,,144208228,403,Inconclusive,216409690.0,5467.0,50.9016,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
730,743212,3,1,,170466875,403,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
731,743213,3,1,,144208228,403,Inconclusive,,,32.1167,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
732,743213,3,1,,170466875,403,Inconclusive,,,8.412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
733,743215,3,1,,144208228,403,Inconclusive,216409690.0,5467.0,36.0356,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
734,743215,3,1,,170466875,403,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
735,743217,3,1,,144208228,403,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
736,743217,3,1,,170466875,403,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
737,743218,3,1,,144208228,403,Active,,,25.5112,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
738,743218,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
739,743219,3,1,,144208228,403,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
740,743219,3,1,,170466875,403,Inconclusive,20149576.0,4780.0,29.846999999999998,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
741,743220,3,1,,144208228,403,Active,325495553.0,9971.0,20.2643,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
742,743220,3,1,,170466875,403,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
743,743221,3,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
744,743221,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
745,743222,3,1,,144208228,403,Inconclusive,216409708.0,7421.0,57.1125,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
746,743222,3,1,,170466875,403,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
747,743223,3,1,,144208228,403,Inconclusive,216409708.0,7421.0,22.7369,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
748,743223,3,1,,170466875,403,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
749,743224,3,1,,144208228,403,Inconclusive,,,12.7859,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
750,743224,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
751,743225,3,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
752,743225,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
753,743226,2,1,,144208228,403,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
754,743226,2,1,,170466875,403,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
755,743227,2,1,,144208228,403,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
756,743227,2,1,,170466875,403,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
757,743228,3,1,,144208228,403,Active,4504517.0,3315.0,19.1307,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
758,743228,3,1,,170466875,403,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
759,743239,2,1,,144208228,403,Inconclusive,325495553.0,9971.0,21.0571,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
760,743239,2,1,,170466875,403,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
761,743240,2,1,,144208228,403,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
762,743240,2,1,,170466875,403,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
763,743241,2,1,,144208228,403,Inconclusive,216409708.0,7421.0,30.3201,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
764,743241,2,1,,170466875,403,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
765,743242,2,1,,144208228,403,Active,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
766,743242,2,1,,170466875,403,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
767,743244,1,1,,144206793,403,Inconclusive,,,25.1189,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
768,743244,1,1,,144207026,403,Inconclusive,,,35.4813,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
769,743288,1,1,,17388802,403,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
770,743292,1,1,,17388802,403,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
771,1117298,1,2,,170466875,403,Unspecified,,,,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
772,1117304,1,2,,170466875,403,Inactive,,,8.9125,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
773,1117305,1,2,,170466875,403,Inactive,,,4.4668,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
774,1117310,1,1,,170466875,403,Inactive,,,,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
775,1117312,1,1,,170466875,403,Inactive,,,4.46684,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
776,1117314,1,1,,170466875,403,Inactive,,,8.912510000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
777,1117324,1,1,,170466875,403,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
778,1117326,1,1,,170466875,403,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
779,1117329,1,1,,170466875,403,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
780,1117336,1,1,,170466875,403,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
781,1117337,1,1,,170466875,403,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
782,1117340,1,1,,170466875,403,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
783,1117341,1,1,,170466875,403,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
784,1117342,1,1,,170466875,403,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
785,1117343,1,1,,170466875,403,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
786,1117346,1,1,,170466875,403,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
787,1121261,1,1,,103329767,403,Unspecified,,,,,Cytotoxicity against human HL60 cells assessed as cell viability up to 120 uM after 24 hrs by trypan blue assay,Other,,
788,1121263,1,2,,103329767,403,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging rate constant measured for 60 secs by spectrophotometric analysis,Other,,
789,1123154,1,1,,103329767,403,Unspecified,,,,,"Hypobetalipoproteinemic activity in diet-induced hypercholesteremic rat model assessed as decrease in total serum cholesterol at 50 mg/kg, po relative to control",Other,218007.0,
790,1123155,1,1,,103329767,403,Unspecified,,,,,"Hypobetalipoproteinemic activity in diet-induced hypercholesteremic rat model assessed as decrease in heparin precipitating lipoproteins at 50 mg/kg, po relative to control",Other,218007.0,
791,1123156,1,1,,103329767,403,Unspecified,,,,,Selectivity ratio of T/C for heparin precipitating lipoproteins to T/C for total serum cholesterol in diet-induced hypercholesteremic rat model,Other,218007.0,
792,1123157,1,1,,103329767,403,Unspecified,,,,,"Toxicity in diet-induced hypercholesteremic rat model assessed as increase in body weight at 50 mg/kg, po relative to control",Other,218007.0,
793,1123158,1,1,,103329767,403,Unspecified,,,,,"Toxicity in diet-induced hypercholesteremic rat model assessed as increase in food intake at 50 mg/kg, po relative to control",Other,218007.0,
794,1159509,1,1,,144208228,403,Inconclusive,119626539.0,4790.0,57.1125,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
795,1159509,1,1,,170466875,403,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
796,1159515,1,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
797,1159515,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
798,1159516,1,1,,144208228,403,Inconclusive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
799,1159516,1,1,,170466875,403,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
800,1159517,1,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
801,1159517,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
802,1159518,1,1,,144208228,403,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
803,1159518,1,1,,170466875,403,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
804,1159519,1,1,,144208228,403,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
805,1159519,1,1,,170466875,403,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
806,1159520,1,1,,144208228,403,Active,,,63.5004,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
807,1159520,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
808,1159521,1,1,,144208228,403,Active,15928672.0,19885.0,31.8256,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
809,1159521,1,1,,170466875,403,Inactive,15928672.0,19885.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
810,1159523,1,1,,144208228,403,Inconclusive,15928672.0,19885.0,28.3646,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
811,1159523,1,1,,170466875,403,Inconclusive,15928672.0,19885.0,18.8336,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
812,1159525,1,1,,144208228,403,Active,,,32.1167,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
813,1159525,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
814,1159526,1,1,,144208228,403,Inconclusive,119627033.0,3725.0,16.0965,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
815,1159526,1,1,,170466875,403,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
816,1159527,1,1,,144208228,403,Inconclusive,325495497.0,6256.0,50.9016,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
817,1159527,1,1,,170466875,403,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
818,1159528,1,1,,144208228,403,Inconclusive,119627033.0,3725.0,8.54538,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
819,1159528,1,1,,170466875,403,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
820,1159529,1,1,,144208228,403,Inconclusive,,,45.3661,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
821,1159529,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
822,1159531,1,1,,144208228,403,Inconclusive,325495497.0,6256.0,18.0606,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
823,1159531,1,1,,170466875,403,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
824,1159551,1,1,,144208228,403,Inconclusive,,,63.5004,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
825,1159551,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
826,1159552,1,1,,144208228,403,Inactive,325495463.0,5914.0,20.0806,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
827,1159552,1,1,,170466875,403,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
828,1159553,2,1,,144208228,403,Active,325495463.0,5914.0,20.0806,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
829,1159553,2,1,,170466875,403,Inconclusive,325495463.0,5914.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
830,1159555,1,1,,144208228,403,Inconclusive,325495463.0,5914.0,20.0806,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
831,1159555,1,1,,170466875,403,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
832,1159614,1,2,,170466875,403,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
833,1224834,3,1,,144208228,403,Active,,,31.8256,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
834,1224834,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
835,1224835,1,1,,144208228,403,Active,160794.0,,65.74600000000001,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
836,1224835,1,1,,170466875,403,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
837,1224836,1,1,,144208228,403,Active,,,28.3646,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
838,1224836,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
839,1224837,1,1,,144208228,403,Active,,,28.3646,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
840,1224837,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
841,1224838,1,1,,144208228,403,Active,66775687.0,9970.0,40.0661,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
842,1224838,1,1,,170466875,403,Inactive,66775687.0,9970.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
843,1224839,1,1,,144208228,403,Inactive,66775687.0,9970.0,31.8256,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
844,1224839,1,1,,170466875,403,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
845,1224840,3,1,,144208228,403,Active,,,35.7089,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
846,1224840,3,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
847,1224841,3,1,,144208228,403,Active,325495545.0,2101.0,44.9549,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
848,1224841,3,1,,170466875,403,Inactive,325495545.0,2101.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
849,1224842,3,1,,144208228,403,Inactive,325495545.0,2101.0,50.4402,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
850,1224842,3,1,,170466875,403,Inconclusive,325495545.0,2101.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
851,1224843,1,1,,144208228,403,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
852,1224843,1,1,,170466875,403,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
853,1224844,1,1,,144208228,403,Active,,,50.9016,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
854,1224844,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
855,1224845,1,1,,144208228,403,Inconclusive,344243002.0,100757539.0,58.8525,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
856,1224845,1,1,,170466875,403,Inconclusive,344243002.0,100757539.0,21.9741,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
857,1224846,1,1,,144208228,403,Inconclusive,11995455.0,3091.0,57.1125,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
858,1224846,1,1,,170466875,403,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
859,1224847,1,1,,144208228,403,Inconclusive,,,104.656,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
860,1224847,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
861,1224848,3,1,,144208228,403,Active,325495545.0,2101.0,22.5308,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
862,1224848,3,1,,170466875,403,Inactive,325495545.0,2101.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
863,1224849,3,1,,144208228,403,Inactive,325495545.0,2101.0,22.5308,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
864,1224849,3,1,,170466875,403,Inconclusive,325495545.0,2101.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
865,1224857,2,1,,170466875,403,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
866,1224859,2,1,,170466875,403,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
867,1224867,1,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
868,1224867,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
869,1224868,1,1,,144208228,403,Active,,,32.1167,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
870,1224868,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
871,1224869,1,1,,144208228,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
872,1224869,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
873,1224870,1,1,,144208228,403,Inconclusive,,,64.0813,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
874,1224870,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
875,1224871,1,1,,144208228,403,Active,,,25.5112,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
876,1224871,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
877,1224872,1,1,,144208228,403,Active,,,40.4326,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
878,1224872,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
879,1224873,1,1,,144208228,403,Active,,,50.9016,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
880,1224873,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
881,1224874,1,1,,144208228,403,Active,,,32.1167,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
882,1224874,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
883,1224875,1,1,,144208228,403,Inactive,,,64.0813,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
884,1224875,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
885,1224876,1,1,,144208228,403,Inconclusive,,,64.0813,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
886,1224876,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
887,1224877,1,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
888,1224877,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
889,1224878,1,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
890,1224878,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
891,1224879,1,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
892,1224879,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
893,1224880,1,1,,144208228,403,Inconclusive,,,45.3661,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
894,1224880,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
895,1224881,1,1,,144208228,403,Inconclusive,,,50.9016,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
896,1224881,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
897,1224882,1,1,,144208228,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
898,1224882,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
899,1224883,1,1,,144208228,403,Inconclusive,,,57.1125,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
900,1224883,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
901,1224884,1,1,,144208228,403,Inactive,,,57.1125,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
902,1224884,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
903,1224885,1,1,,144208228,403,Active,,,57.1125,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
904,1224885,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
905,1224886,1,1,,144208228,403,Active,,,40.4326,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
906,1224886,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
907,1224887,1,1,,144208228,403,Active,,,40.4326,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
908,1224887,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
909,1224888,1,1,,144208228,403,Inactive,,,64.0813,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
910,1224888,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
911,1224889,1,1,,144208228,403,Inconclusive,,,45.3661,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
912,1224889,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
913,1224890,1,1,,144208228,403,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
914,1224890,1,1,,170466875,403,Inconclusive,,,9.5205,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
915,1224892,1,1,,144208228,403,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
916,1224892,1,1,,170466875,403,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
917,1224893,1,1,,144208228,403,Inconclusive,66775687.0,9970.0,44.9549,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
918,1224893,1,1,,170466875,403,Inconclusive,66775687.0,9970.0,21.9584,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
919,1224894,1,1,,144208228,403,Inconclusive,11995455.0,3091.0,50.9016,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
920,1224894,1,1,,170466875,403,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
921,1224895,1,1,,144208228,403,Inconclusive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
922,1224895,1,1,,170466875,403,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
923,1224896,1,1,,144208228,403,Active,344243002.0,100757539.0,91.1517,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
924,1224896,1,1,,170466875,403,Active,344243002.0,100757539.0,32.8785,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
925,1259241,1,1,,144208228,403,Active,,,28.3646,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
926,1259241,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
927,1259242,1,1,,144208228,403,Active,,,50.4402,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
928,1259242,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
929,1259243,1,1,,144208228,403,Active,124375976.0,367.0,25.28,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
930,1259243,1,1,,170466875,403,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
931,1259244,1,1,,144208228,403,Active,348019627.0,2099.0,28.3646,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
932,1259244,1,1,,170466875,403,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
933,1259247,1,1,,144208228,403,Inconclusive,124375976.0,367.0,25.28,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
934,1259247,1,1,,170466875,403,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
935,1259248,1,1,,144208228,403,Inconclusive,348019627.0,2099.0,47.6186,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
936,1259248,1,1,,170466875,403,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
937,1259344,1,1,,144206793,403,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
938,1259344,1,1,,144207026,403,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
939,1259364,1,1,,144208228,403,Inconclusive,1013403374.0,9734.0,56.5948,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
940,1259364,1,1,,170466875,403,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
941,1259365,1,1,,144208228,403,Inconclusive,,,71.2487,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
942,1259365,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
943,1259366,1,1,,144208228,403,Active,,,17.8969,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
944,1259366,1,1,,170466875,403,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
945,1259367,1,1,,144208228,403,Active,,,31.8256,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
946,1259367,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
947,1259368,1,1,,144208228,403,Inactive,109731339.0,2737.0,31.8256,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
948,1259368,1,1,,170466875,403,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
949,1259369,1,1,,144208228,403,Active,109731339.0,2737.0,7.9942,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
950,1259369,1,1,,170466875,403,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
951,1259377,1,1,,144208228,403,Inconclusive,54288833.0,2100.0,25.28,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
952,1259377,1,1,,170466875,403,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
953,1259378,1,1,,144208228,403,Inconclusive,54288833.0,2100.0,28.3646,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
954,1259378,1,1,,170466875,403,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
955,1259379,1,1,,144208228,403,Active,,,56.5948,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
956,1259379,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
957,1259380,1,1,,144208228,403,Inconclusive,,,31.8256,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
958,1259380,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
959,1259381,1,1,,144208228,403,Active,124375976.0,367.0,5.044,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
960,1259381,1,1,,170466875,403,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
961,1259382,1,1,,144208228,403,Active,,,63.5004,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
962,1259382,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
963,1259383,1,1,,144208228,403,Inactive,348019627.0,2099.0,40.0661,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
964,1259383,1,1,,170466875,403,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
965,1259384,1,1,,144208228,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
966,1259384,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
967,1259385,1,1,,144208228,403,Inconclusive,119601739.0,7253.0,40.0661,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
968,1259385,1,1,,170466875,403,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
969,1259386,1,1,,144208228,403,Active,,,31.8256,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
970,1259386,1,1,,170466875,403,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
971,1259387,1,1,,144208228,403,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
972,1259387,1,1,,170466875,403,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
973,1259388,1,1,,144208228,403,Active,1013403374.0,9734.0,54.0476,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
974,1259388,1,1,,170466875,403,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
975,1259390,1,1,,144208228,403,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
976,1259390,1,1,,170466875,403,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
977,1259391,1,1,,144208228,403,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
978,1259391,1,1,,170466875,403,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
979,1259392,1,1,,144208228,403,Active,109731339.0,2737.0,10.6605,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
980,1259392,1,1,,170466875,403,Inconclusive,109731339.0,2737.0,33.4915,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
981,1259393,1,1,,144208228,403,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
982,1259393,1,1,,170466875,403,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
983,1259394,1,1,,144208228,403,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
984,1259394,1,1,,170466875,403,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
985,1259395,1,1,,144208228,403,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
986,1259395,1,1,,170466875,403,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
987,1259396,1,1,,144208228,403,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
988,1259396,1,1,,170466875,403,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
989,1259400,1,1,,170466875,403,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
990,1259401,1,1,,144208228,403,Inconclusive,325495545.0,2101.0,35.7089,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
991,1259401,1,1,,170466875,403,Inconclusive,325495545.0,2101.0,29.8493,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
992,1259402,1,1,,144208228,403,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
993,1259402,1,1,,170466875,403,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
994,1259403,1,1,,144208228,403,Inconclusive,325495545.0,2101.0,26.269000000000002,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
995,1259403,1,1,,170466875,403,Inconclusive,325495545.0,2101.0,28.1796,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
996,1259404,1,1,,144208228,403,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
997,1259404,1,1,,170466875,403,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
998,1259407,1,1,,363902096,403,Active,,,,,CCRIS mutagenicity studies,Other,,
999,1259408,1,1,,363895386,403,Inactive,,,,,GENE-TOX mutagenicity studies,Other,,
